Clinical Trial Update: A Study of Mircera for the Treatment of Anemia in Dialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Mircera for the treatment of anemia in dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED